Alterations in CD41 expression or function can have significant clinical implications. For instance, mutations in the gene encoding CD41 (ITGA2B) can lead to Glanzmann thrombasthenia, a rare bleeding disorder characterized by defective platelet aggregation. Additionally, CD41 is used as a marker in the diagnosis of certain leukemias and other hematological malignancies.
